对于胃食道逆流性疾病的神经调节:系统性审查
Jia Yi Woo1, Victor Pikov2, Jiande D Z Chen3
1Northern Health, Epping, Victoria, Australia.
概括
神经调节疗法,包括电刺激,声刺激和针,有效地治疗胃食道逆流性疾病 (GERD) 症状和潜在原因. 这些方法为GERD患者提供安全,个性化的治疗选择.
科学领域:
- 胃肠病学 胃肠病学
- 神经学 神经学
- 医疗器械 医疗器械
背景情况:
- 胃食道逆流性疾病 (GERD) 影响全球数以百万计的人,需要新的治疗方法.
- 了解GERD神经调节的机制和疗效对于推进患者护理至关重要.
研究的目的:
- 系统地审查三种神经调节治疗GERD的疗效,机制和安全性.
- 评估这些疗法对GERD症状和关键病理生理因素的影响.
主要方法:
- 系统的文献审查遵循PRISMA指南.
- 搜索了Medline,Embase和PubMed数据库;使用Covidence软件评估了研究.
- 包括13项临床研究,评估LES电刺激,穿皮电声刺激和手动针.
主要成果:
- 所有神经调节疗法都显著改善了GERD症状.
- 电刺激增加了食道下关节 (LES) 压力;声刺激改善了食道和胃的运动性和副交感活动.
- 对于任何评估的神经调节方法,没有报告严重的不良反应.
结论:
- 神经调节疗法在管理GERD症状和解决潜在的病理生理机制方面是有效的.
- 这些疗法代表了个性化GERD治疗策略的有价值,安全的选择.
相关概念视频
Gastroesophageal Reflux Disease II: Clinical Features and Management
88
Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
88
Gastroesophageal Reflux Disease I: Meaning and Pathophysiology
320
Gastroesophageal Reflux Disease (GERD) involves the recurrent backflow of the stomach or duodenal contents into the esophagus, leading to troublesome symptoms and potential esophageal mucosal damage. Although GERD is often referred to as a disease, it is more accurately described as a syndrome, as it encompasses a range of symptoms and complications rather than a singular pathological entity, impacting a large number of individuals as the most prevalent upper gastrointestinal problem. Roughly...
320
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
266
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
266
Peptic Ulcer Disease IV: Management
95
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
95
Barrett Esophagus-II: Clinical Manifestations and Management
158
Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
158
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
342
Prokinetic agents are specialized medications that stimulate gastrointestinal (GI) motility, promoting food movement through the GI tract. Dopamine, an inhibitory neurotransmitter, plays a significant role in this process, reducing GI motility and indirectly controlling the speed of digestion. Dopamine receptor antagonists, such as metoclopramide and domperidone, offer a unique advantage as prokinetic agents. By blocking the dopamine receptors, these drugs increase GI motility, improving food...
342


